Corticotropin-releasing hormone antagonists, astressin B and antalarmin: differing profiles of activity in rhesus monkeys (Q44784145)

6 December 2017

Corticotropin-releasing hormone antagonists, astressin B and antalarmin: differing profiles of activity in rhesus monkeys (English)

1 reference

6 December 2017

1

1 reference

6 December 2017

Gail Winger

2

1 reference

6 December 2017

Jean E Rivier

series ordinal

3

1 reference

6 December 2017

Kenner C Rice

series ordinal

4

1 reference

6 December 2017

James H Woods

series ordinal

5

1 reference

6 December 2017

language of work or name

English

0 references

publication date

1 June 2004

1 reference

6 December 2017

Neuropsychopharmacology

1 reference

6 December 2017

29

1 reference

6 December 2017

1112-1121

1 reference

6 December 2017

6

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.npp.1300410

6 December 2017

0 references

cites work

Chronic effects of a nonpeptide corticotropin-releasing hormone type I receptor antagonist on pituitary-adrenal function, body weight, and metabolic regulation.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300410

Antalarmin, a putative CRH-RI antagonist, has transient reinforcing effects in rhesus monkeys

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300410

Perturbations of plasma cortisol and DHEA-S following discontinuation of cocaine use in cocaine addicts

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300410

Synthesis and oral efficacy of a 4-(butylethylamino)pyrrolo[2,3-d]pyrimidine: a centrally active corticotropin-releasing factor1 receptor antagonist.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300410

The Impact of the Nonpeptide Corticotropin-Releasing Hormone Antagonist Antalarmin on Behavioral and Endocrine Responses to Stress1

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300410

A neuroendocrine role in cocaine reinforcement

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300410

Effects of the CRH receptor antagonist CP-154,526 on intravenous cocaine self-administration in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300410

Characterization of the behavioral profile of the non-peptide CRF receptor antagonist CP-154,526 in anxiety models in rodents. Comparison with diazepam and buspirone.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300410

Potent, structurally constrained agonists and competitive antagonists of corticotropin-releasing factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300410

Oral administration of a corticotropin-releasing hormone receptor antagonist significantly attenuates behavioral, neuroendocrine, and autonomic responses to stress in primates

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300410

Synthesis and relative potencies of new constrained CRF antagonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300410

The rationale for corticotropin-releasing hormone receptor (CRH-R) antagonists to treat depression and anxiety

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300410

Unidirectional specific and modulated brain to blood transport of corticotropin-releasing hormone.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300410

Allostasis and allostatic load: implications for neuropsychopharmacology

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300410

KINETICS OF MOVEMENT OF IODIDE, SUCROSE, INULIN AND RADIO-IODINATED SERUM ALBUMIN IN THE CENTRAL NERVOUS SYSTEM AND CEREBROSPINAL FLUID OF THE RAT.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300410

Role of corticotropin-releasing factor receptors type 1 and 2 in modulating the rat adrenocorticotropin response to stressors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300410

Constrained corticotropin releasing factor antagonists (astressin analogues) with long duration of action in the rat

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300410

CP-154,526: a potent and selective nonpeptide antagonist of corticotropin releasing factor receptors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300410

CP-154,526, a selective, non-peptide antagonist of the corticotropin-releasing factor1 receptor attenuates stress-induced relapse to drug seeking in cocaine- and heroin-trained rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300410

In vivo and in vitro characterization of antalarmin, a nonpeptide corticotropin-releasing hormone (CRH) receptor antagonist: suppression of pituitary ACTH release and peripheral inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300410

Chronic administration of the non-peptide CRH type 1 receptor antagonist antalarmin does not blunt hypothalamic-pituitary-adrenal axis responses to acute immobilization stress.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300410

Alterations in hypothalamic-pituitary-adrenal axis activity and in levels of proopiomelanocortin and corticotropin-releasing hormone-receptor 1 mRNAs in the pituitary and hypothalamus of the rat during chronic 'binge' cocaine and withdrawal

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300410

Mechanisms by which blood levels of interleukin-6 (IL-6) are elevated after intracerebroventricular injection of IL-1beta in the rat: neural versus humoral control

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300410

7 January 2021

4-(2-Chloro-4-methoxy-5-methylphenyl)-N-[(1S)-2-cyclopropyl-1-(3-fluoro-4-methylphenyl)ethyl]5-methyl-N-(2-propynyl)-1, 3-thiazol-2-amine hydrochloride (SSR125543A), a potent and selective corticotrophin-releasing factor(1) receptor antagonist. II.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300410

7 January 2021

Synthetic Competitive Antagonists of Corticotropin-Releasing Factor: Effect on ACTH Secretion in the Rat

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300410

7 January 2021

Intracerebroventricular passive immunization. II. Intracerebroventricular infusion of neuropeptide antisera can inhibit neuropeptide signaling in peripheral tissues

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300410

7 January 2021

Identifiers

DOI

10.1038/SJ.NPP.1300410

1 reference

6 December 2017

1 reference